bpc 157 subq or im BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA BPC 157 - Precision Performance
Description
Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President

The reward system goes quiet

Standard Knee Protocol Dosage: 250-500 mcg per day, injected subcutaneously near the knee

300 mcg daily
